251 related articles for article (PubMed ID: 28038953)
21. Synthetic Consortium of Escherichia coli for n-Butanol Production by Fermentation of the Glucose-Xylose Mixture.
Saini M; Lin LJ; Chiang CJ; Chao YP
J Agric Food Chem; 2017 Nov; 65(46):10040-10047. PubMed ID: 29076337
[TBL] [Abstract][Full Text] [Related]
22. Potential production platform of n-butanol in Escherichia coli.
Saini M; Hong Chen M; Chiang CJ; Chao YP
Metab Eng; 2015 Jan; 27():76-82. PubMed ID: 25461833
[TBL] [Abstract][Full Text] [Related]
23. Production of soluble and functional engineered antibodies in Escherichia coli improved by FkpA.
Zhang Z; Song LP; Fang M; Wang F; He D; Zhao R; Liu J; Zhou ZY; Yin CC; Lin Q; Huang HL
Biotechniques; 2003 Nov; 35(5):1032-8, 1041-2. PubMed ID: 14628677
[TBL] [Abstract][Full Text] [Related]
24. Engineering nonphosphorylative metabolism to synthesize mesaconate from lignocellulosic sugars in Escherichia coli.
Bai W; Tai YS; Wang J; Wang J; Jambunathan P; Fox KJ; Zhang K
Metab Eng; 2016 Nov; 38():285-292. PubMed ID: 27697562
[TBL] [Abstract][Full Text] [Related]
25. Engineering Escherichia coli Cell Factories for n-Butanol Production.
Dong H; Zhao C; Zhang T; Lin Z; Li Y; Zhang Y
Adv Biochem Eng Biotechnol; 2016; 155():141-63. PubMed ID: 25662903
[TBL] [Abstract][Full Text] [Related]
26. Model-based metabolic engineering enables high yield itaconic acid production by Escherichia coli.
Harder BJ; Bettenbrock K; Klamt S
Metab Eng; 2016 Nov; 38():29-37. PubMed ID: 27269589
[TBL] [Abstract][Full Text] [Related]
27. CRISPR/Cas9-mediated engineering of Escherichia coli for n-butanol production from xylose in defined medium.
Abdelaal AS; Jawed K; Yazdani SS
J Ind Microbiol Biotechnol; 2019 Jul; 46(7):965-975. PubMed ID: 30982114
[TBL] [Abstract][Full Text] [Related]
28. Engineering the intracellular metabolism of Escherichia coli to produce gamma-aminobutyric acid by co-localization of GABA shunt enzymes.
Pham VD; Somasundaram S; Lee SH; Park SJ; Hong SH
Biotechnol Lett; 2016 Feb; 38(2):321-7. PubMed ID: 26476527
[TBL] [Abstract][Full Text] [Related]
29. E. coli metabolic engineering for gram scale production of a plant-based anti-inflammatory agent.
Ahmadi MK; Fang L; Moscatello N; Pfeifer BA
Metab Eng; 2016 Nov; 38():382-388. PubMed ID: 27718358
[TBL] [Abstract][Full Text] [Related]
30. Engineering the biological conversion of methanol to specialty chemicals in Escherichia coli.
Whitaker WB; Jones JA; Bennett RK; Gonzalez JE; Vernacchio VR; Collins SM; Palmer MA; Schmidt S; Antoniewicz MR; Koffas MA; Papoutsakis ET
Metab Eng; 2017 Jan; 39():49-59. PubMed ID: 27815193
[TBL] [Abstract][Full Text] [Related]
31. [Construction of butanol-producing pathway from Clostridium saccharobutylicum in Escherichia coli JM109 (DE3) and its fermentation].
Li J; Han R; Xu G; Dong J; Ni Y
Wei Sheng Wu Xue Bao; 2015 Nov; 55(11):1427-36. PubMed ID: 26915224
[TBL] [Abstract][Full Text] [Related]
32. Engineering Escherichia coli for the synthesis of short- and medium-chain α,β-unsaturated carboxylic acids.
Kim S; Cheong S; Gonzalez R
Metab Eng; 2016 Jul; 36():90-98. PubMed ID: 26996381
[TBL] [Abstract][Full Text] [Related]
33. Engineering alternative butanol production platforms in heterologous bacteria.
Nielsen DR; Leonard E; Yoon SH; Tseng HC; Yuan C; Prather KL
Metab Eng; 2009; 11(4-5):262-73. PubMed ID: 19464384
[TBL] [Abstract][Full Text] [Related]
34. Engineering Escherichia coli to produce branched-chain fatty acids in high percentages.
Bentley GJ; Jiang W; Guamán LP; Xiao Y; Zhang F
Metab Eng; 2016 Nov; 38():148-158. PubMed ID: 27421620
[TBL] [Abstract][Full Text] [Related]
35. Metabolic engineering of Escherichia coli for microbial synthesis of monolignols.
Chen Z; Sun X; Li Y; Yan Y; Yuan Q
Metab Eng; 2017 Jan; 39():102-109. PubMed ID: 27816771
[TBL] [Abstract][Full Text] [Related]
36. Metabolomics-driven approach to solving a CoA imbalance for improved 1-butanol production in Escherichia coli.
Ohtake T; Pontrelli S; Laviña WA; Liao JC; Putri SP; Fukusaki E
Metab Eng; 2017 May; 41():135-143. PubMed ID: 28400330
[TBL] [Abstract][Full Text] [Related]
37. A synthetic O2 -tolerant butanol pathway exploiting native fatty acid biosynthesis in Escherichia coli.
Pásztor A; Kallio P; Malatinszky D; Akhtar MK; Jones PR
Biotechnol Bioeng; 2015 Jan; 112(1):120-8. PubMed ID: 24981220
[TBL] [Abstract][Full Text] [Related]
38. Controlling Citrate Synthase Expression by CRISPR/Cas9 Genome Editing for n-Butanol Production in Escherichia coli.
Heo MJ; Jung HM; Um J; Lee SW; Oh MK
ACS Synth Biol; 2017 Feb; 6(2):182-189. PubMed ID: 27700055
[TBL] [Abstract][Full Text] [Related]
39. Towards improved butanol production through targeted genetic modification of Clostridium pasteurianum.
Schwarz KM; Grosse-Honebrink A; Derecka K; Rotta C; Zhang Y; Minton NP
Metab Eng; 2017 Mar; 40():124-137. PubMed ID: 28119139
[TBL] [Abstract][Full Text] [Related]
40. Application of an E. coli signal sequence as a versatile inclusion body tag.
Jong WS; Vikström D; Houben D; van den Berg van Saparoea HB; de Gier JW; Luirink J
Microb Cell Fact; 2017 Mar; 16(1):50. PubMed ID: 28320377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
